Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P13
Within normal range
vs 3Y Ago
-0.9x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -10.51% |
| Q3 2025 | 0.14% |
| Q2 2025 | 2.21% |
| Q1 2025 | -0.22% |
| Q4 2024 | -2.23% |
| Q3 2024 | -4.00% |
| Q2 2024 | 3.06% |
| Q1 2024 | 331.29% |
| Q4 2023 | -76.05% |
| Q3 2023 | -3.27% |
| Q2 2023 | -7.25% |
| Q1 2023 | 3.55% |
| Q4 2022 | 12.26% |
| Q3 2022 | 2.68% |
| Q2 2022 | 14.92% |
| Q1 2022 | -21.84% |
| Q4 2021 | -21.48% |
| Q3 2021 | 33.68% |
| Q2 2021 | -7.35% |
| Q1 2021 | 0.00% |
| Q4 2020 | -100.00% |
| Q3 2020 | 15.55% |
| Q2 2020 | -19.19% |
| Q1 2020 | -1.99% |
| Q4 2019 | 0.07% |
| Q3 2019 | -9.55% |
| Q2 2019 | 6.54% |
| Q1 2019 | 3.99% |
| Q4 2018 | 4.08% |
| Q3 2018 | 7.00% |
| Q2 2018 | 5.47% |
| Q1 2018 | -0.26% |
| Q4 2017 | 0.17% |
| Q3 2017 | -5.65% |
| Q2 2017 | 0.00% |
| Q1 2017 | 1.50% |
| Q4 2016 | 7.51% |
| Q3 2016 | 22.56% |
| Q2 2016 | 0.88% |
| Q1 2016 | -0.33% |